Cargando…
Microdissected Tissue vs. Tissue Slices—A Comparative Study of Tumor Explant Models Cultured On-Chip and Off-Chip
SIMPLE SUMMARY: Cancer drugs have the lowest success rate of approval in drug development programs. In order to address this, predictive preclinical assays that correctly reflect the clinical efficacy of a drug represent an urgent need in both clinical oncology and pharmaceutical research. To addres...
Autores principales: | Dorrigiv, Dina, Simeone, Kayla, Communal, Laudine, Kendall-Dupont, Jennifer, St-Georges-Robillard, Amélie, Péant, Benjamin, Carmona, Euridice, Mes-Masson, Anne-Marie, Gervais, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394960/ https://www.ncbi.nlm.nih.gov/pubmed/34439362 http://dx.doi.org/10.3390/cancers13164208 |
Ejemplares similares
-
Pixelated Microfluidics for Drug Screening on Tumour Spheroids and Ex Vivo Microdissected Tumour Explants
por: Dorrigiv, Dina, et al.
Publicado: (2023) -
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay
por: Labouba, Ingrid, et al.
Publicado: (2015) -
Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers
por: Labrie, Marilyne, et al.
Publicado: (2017) -
Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
por: Fleury, Hubert, et al.
Publicado: (2015)